Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2009-07-21 Lowe David George Director Sale −78,800 $3.94 $310K 129,600
2009-07-20 Lowe David George Director Sale −102,000 $4.44 $453K 208,400
2009-07-17 Lowe David George Director Sale −25,000 $4.19 $105K 310,400
2009-06-15 Lowe David George Director Sale −6,100 $3.90 $24K 335,400
2009-06-12 Lowe David George Director Sale −3,800 $3.94 $15K 341,500
2009-06-11 Lowe David George Director Sale −40,700 $3.84 $156K 345,300
2009-06-10 Lowe David George Director Sale −36,000 $3.96 $142K 386,000
2009-06-09 Lowe David George Director Sale −47,500 $3.99 $189K 422,000
2009-06-08 Lowe David George Director Sale −65,708 $4.21 $276K 469,500
2009-06-01 Lowe David George Director Other disposition −342,375 535,208
2009-02-27 Lowe David George Director Grant or award · Option to Purchase Common Stock +7,500 7,500

Page 1 of 1 · 11 trades